These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 146583)

  • 41. [Detection of fetal growth retardation by instrumental and biochemical monitoring methods].
    Pfeiffer KH
    Z Geburtshilfe Perinatol; 1990; 194(3):99-103. PubMed ID: 2198727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Echographic and hormonal parameters in fetal growth retardation].
    Ruseva R
    Akush Ginekol (Sofiia); 1988; 27(5):15-8. PubMed ID: 3066230
    [No Abstract]   [Full Text] [Related]  

  • 43. Obstetric management of the growth retarded baby.
    Simpson GF; Creasy RK
    Clin Obstet Gynaecol; 1984 Aug; 11(2):481-97. PubMed ID: 6383686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biparietal measurements, human placental lactogenic hormone and estradiol in the evaluation of the fetus].
    Berendtsen H; Klünder KB; Nørskov O
    Ugeskr Laeger; 1985 Sep; 147(38):2984-6. PubMed ID: 3907070
    [No Abstract]   [Full Text] [Related]  

  • 45. The small fetus: growth-retarded and preterm.
    Tambyraja RL; Ratnam SS
    Clin Obstet Gynaecol; 1982 Dec; 9(3):517-37. PubMed ID: 6756748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
    Kullander S; Marsál K; Persson PH
    Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
    [No Abstract]   [Full Text] [Related]  

  • 47. Human placental lactogen and other placental proteins as indicators of fetal well-being.
    Varner MW; Hauser KS
    Clin Obstet Gynecol; 1982 Dec; 25(4):673-88. PubMed ID: 6186425
    [No Abstract]   [Full Text] [Related]  

  • 48. CAP, HCS and urinary estriol measurements in risk pregnancies--a comparative study.
    Rydén G; Kågedal B
    J Perinat Med; 1977; 5(6):244-51. PubMed ID: 611164
    [No Abstract]   [Full Text] [Related]  

  • 49. [Counting active movements of the fetus: could it be useful?].
    De Muylder X
    Can Med Assoc J; 1982 Dec; 127(12):1172-5, 1194. PubMed ID: 6754052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of hPL in the diagnosis of intrauterine growth retardation.
    Gohari P; Hobbins JC; Berkowtiz R
    Obstet Gynecol; 1978 Jul; 52(1):127-8. PubMed ID: 683623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relation between ultrasonic and hormonal parameters in fetal hypotrophy].
    Ruseva R; Marinov B
    Akush Ginekol (Sofiia); 1984; 23(1):52-6. PubMed ID: 6721116
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fetal growth retardation. 1983 experience at the Hospital Paula Jaraquemada].
    Bianchi R; Martorell R; Kirssinger C; Díaz L; Ortiz M
    Rev Chil Obstet Ginecol; 1984; 49(6):400-9. PubMed ID: 6400347
    [No Abstract]   [Full Text] [Related]  

  • 53. [Ultrasonic and biochemical detection and prenatal treatments of intra-uterine fetal growth retardation (author's transl)].
    Kaneoka T; Aso M; Nobori M; Aonuma M; Shimizu H; Shirakawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jan; 32(1):103-12. PubMed ID: 6165785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The predictive value of three pregnancy-associated proteins in the detection of the light-for-dates baby.
    Pledger DR; Belfield A; Calder AA; Wallace AM
    Br J Obstet Gynaecol; 1984 Sep; 91(9):870-4. PubMed ID: 6206887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal movement monitoring in normal and high-risk pregnancy.
    Ehrström C
    Acta Obstet Gynecol Scand Suppl; 1979; 80():1-32. PubMed ID: 283683
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of fetuses in the late pregnancy by serial determinations of serum human placental lactogen levels].
    Kaibara M; Marumoto Y; Taniguchi I; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1724-8. PubMed ID: 7175278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormone assays in diagnosis of high-risk pregnancy.
    White P
    Postgrad Med; 1976 Jun; 59(6):121-4. PubMed ID: 934952
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum free estriol inefficient in the detection of intrauterine growth retardation.
    Palo P; Erkkola R; Irjala K; Taina E
    Ann Chir Gynaecol Suppl; 1987; 202():20-2. PubMed ID: 3477982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Human placental lactogen determination as one of hormonal parameters in the evaluation of high risk pregnancy in its 3d trimester].
    Lukasik J; Rudzinski J; Wojcikowski C; Kusiak E; Wozniczko J; Emerich J; Stanlinska T
    Ginekol Pol; 1975 Feb; 46(2):129-35. PubMed ID: 1111253
    [No Abstract]   [Full Text] [Related]  

  • 60. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.